what is the name of the monkeypox virus?
Upon recognition of a new monkeypox virus, the best way to communicate it is to give it a proper name.
Appropriate names minimize the risk of offending cultural groups and have minimal impact on animal welfare, trade, and tourism.
To select an appropriate name, experts in evolutionary biology and pox virology reviewed the phylogeny and nomenclature of monkeypox virus variants and discussed their characteristics and evolution.
The differences between the different variants were analyzed as well, as the consequences on public health and trade.
The symptoms of the monkeypox virus are typically fever, chills, and rash. The illness can last anywhere from two to four weeks, depending on the person infected and their health.
The death rate for this virus is low in humans but can reach one in ten people in African countries.
Those at high risk include pregnant women, children, and people with underlying medical conditions or who are immunocompromised.
People who are exposed to the disease should avoid close contact with others and avoid touching their pets.
In addition to washing their personal clothing and bedding, they should also disinfect any surfaces that have been touched by the monkeypox-infected person.
Hand sanitizers containing alcohol are also recommended. Health professionals should follow the guidelines outlined on the website to prevent monkeypox.
These guidelines can be helpful for preventing monkeypox and limiting the severity of the condition.
The transmission of the monkeypox virus can be prevented if health workers who are in contact with infected patients take standard precautions.
These precautions include implementing good hand hygiene and ensuring that contaminated environmental surfaces are properly disinfected.
Additionally, they should not use contaminated medical equipment and waste materials.
When a suspected case is diagnosed, public health measures should be implemented immediately.
The patient should be isolated until the diagnosis has been confirmed by laboratory testing. Monkeypox is typically self-limiting, though severe cases can be fatal.
The disease is generally less severe in the West African clade than in the Congo Basin, and the case fatality is significantly lower.
Public health investigations are ongoing in non-endemic countries, including extensive case findings and laboratory investigations.
In cases of infection, patients are generally treated with isolation and supportive care, and vaccination is offered to close contacts.
The WHO convenes experts to make recommendations for vaccination.
The World Health Organization has published guidelines for the development of vaccines against the monkeypox virus.
These guidelines are designed to reduce the risk of exposure to the monkeypox virus among humans and animals.
However, the risk of monkeypox remains low enough for widespread vaccination against the virus. Vaccines against the monkeypox virus are available in a few countries.
The WHO has encouraged countries that already have adequate vaccine supplies to share them with others.
One of these vaccines is ACAM2000, which is already over 200 million doses in stock.
It is used to protect military personnel and laboratory researchers. However, the U.S.
Centers for Disease Control do not publish data on vaccine effectiveness in humans.
Instead, they cite older studies of animal studies and clinical trials in Africa. Despite these risks, the FDA has approved two vaccines against the monkeypox virus.
The incubation period of the monkeypox virus is between 8.5 and nine days. The virus is transmitted from one person to another via contact with infected animals or the bite of an infected person.
The virus can also be transferred from human to human through materials that have been infected by the monkeypox virus.
Monkeypox is classified as a Hazard Group 3 pathogen and must be handled under sterile conditions in facilities.
Electron microscopy can be used for evaluating the virus and is not routinely used for the diagnosis of this high-risk etiological agent.
The incubation period for monkeypox virus infection varies from individual to individual.
In the case of the United States, the outbreak in 2003 allowed the estimation of the time from exposure to the onset of the illness in 29 patients.
The incubation period was shorter in persons who had previous animal bites and those who had tactile contact with infected animals.
The incubation period of the monkeypox virus is between five and thirteen days in the United States.
The Virus clade of monkeypoX is a highly infectious and contagious disease that is often acquired from contact with an infected animal. It is also often acquired through the preparation of bushmeat, which is the meat of wild animals that is raw or minimally processed.
The virus has been detected in many types of animals throughout Africa, and its primary reservoir is rodents.
Although the disease can infect humans, it is mostly transmitted by rodents.
The illness is usually self-limited, lasting between two to four weeks, although some patients may develop complications.
The case fatality rate (CFR) of monkeypox depends on the viral clade, host factors, and the route of infection.
Historically, the Congo Basin clade has had a CFR of 10%, while the West African clade has a CFR of one to three percent.
The United States experienced an outbreak in 2003, but there were no deaths.
Why is this disease called ‘monkeypox’?
The disease is called monkeypox because it was first identified in colonies of monkeys kept for research in 1958. It was only later detected in humans in 1970.
Can children get monkeypox?
Children can catch monkeypox if they have close contact with someone who has symptoms. Data from previously affected countries show that children are typically more prone to severe disease than adolescents and adults. There have been a small number of children with monkeypox in the current outbreak
Is my risk of catching or getting serious symptoms from monkeypox higher if I have COVID-19, or if I am suffering from long-COVID?
This is a question that health professionals are currently trying to answer. At this time, we don’t yet know whether having COVID-19 or post COVID-19 condition (long-COVID) makes you more vulnerable to monkeypox.
More studies are needed on patients who have or have had infection with the virus that causes COVID-19 or post-COVID-19 condition and now have monkeypox.
What is WHO’s response to stigmatising messaging circulating online related to monkeypox?
We have seen messages stigmatising certain groups of people around this outbreak of monkeypox. We want to make it very clear that this is not right.
First of all, anyone who has close physical contact of any kind with someone who has monkeypox is at risk, regardless of who they are, what they do, who they have sex with or any other factor.
Secondly, stigmatising people because of an illness or a disease is unacceptable. Stigma is only likely to make things worse and stop us from ending this outbreak as fast as we can.
We need to all pull together to support anyone who has been infected or who is helping to take care of people who are unwell.
We know how to stop this disease, and how we can all protect ourselves and others. Stigma and discrimination is never ok, and it is not ok in relation to this outbreak. We are all in this together
What is the monkeypox virus?
the monkeypox virus is an orthopoxvirus
Tell us anything you know about the name of the monkeypox virus
Remember your health is wealth
Please, let us know your thoughts in the comments section.